JARROD PAUL HOLMES
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology SANTA ROSA, CA NPI 1013018035
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology CA GlaxoSmithKline, LLC. All categories
General Payments — all program years on this page
$212,763.02
- Category: General Payments
- Program years: PY2018–2024
- Record count: 513
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $48,271.56 across 55 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $31,900.00 | 7 |
| Consulting Fee | $13,011.50 | 7 |
| Travel and Lodging | $1,706.50 | 7 |
| Food and Beverage | $1,479.57 | 32 |
| Education | $173.99 | 2 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $34,600.22 | 19 |
| ABBVIE INC. | $4,579.66 | 6 |
| ADC Therapeutics America, Inc. | $2,400.00 | 1 |
| Janssen Scientific Affairs, LLC | $2,055.11 | 2 |
| BeiGene USA, Inc. | $1,950.00 | 1 |
| TerSera Therapeutics LLC | $1,886.50 | 1 |
| Janssen Biotech, Inc. | $294.58 | 7 |
| Daiichi Sankyo Inc. | $146.93 | 8 |
| SANOFI-AVENTIS U.S. LLC | $99.00 | 1 |
| Lilly USA, LLC | $88.36 | 3 |
| PFIZER INC. | $34.31 | 1 |
| Merck Sharp & Dohme Corporation | $32.17 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $30.45 | 1 |
| Acerta Pharma LLC | $27.69 | 1 |
| Genentech USA, Inc. | $23.85 | 1 |
| Genmab U.S., Inc. | $22.73 | 1 |
By program year
Records — PY2024 (55)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.